Cognitive Fatigability is Independent of Subjective Cognitive Fatigue and Mood in Multiple Sclerosis.


Journal

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology
ISSN: 1543-3641
Titre abrégé: Cogn Behav Neurol
Pays: United States
ID NLM: 101167278

Informations de publication

Date de publication:
06 2020
Historique:
entrez: 5 6 2020
pubmed: 5 6 2020
medline: 21 10 2020
Statut: ppublish

Résumé

Sustained cognitive testing is used to detect cognitive fatigability and is often considered a substitute for subjective cognitive fatigue (CF). However, the relationship between cognitive fatigability and subjective CF in people with multiple sclerosis (PwMS) remains undetermined. To explore potential associations between fatigability induced by sustained cognitive testing and subjective CF in PwMS. We gave 120 PwMS and 60 demographically matched, healthy individuals the Beck Depression Inventory-FastScreen (BDI-FS) to measure mood and the Modified Fatigue Impact Scale to measure CF. In addition, we used the Quotient ADHD Test, a sustained attention test, to measure cognitive fatigability. We also explored potential correlations between the individuals' performance on the sustained attention test and thalamic volume using recent MRI scans. Forty-one (34.2%) of the PwMS exhibited cognitive fatigability. These 41 were found to be significantly older (P=0.006), had been diagnosed with the disease for longer (P=0.03), had higher scores (P<0.001) on the Expanded Disability Status Scale, and had reduced thalamic volume (P=0.04) compared with the 79 (65.8%) PwMS not exhibiting cognitive fatigability. The PwMS exhibiting cognitive fatigability scored similarly on the BDI-FS (P=0.21) and self-reported similar rates of CF (P=0.62) as the PwMS not exhibiting cognitive fatigability. Cognitive fatigability induced by sustained cognitive testing is not an accurate clinical alternative to subjective CF. This study provides evidence to support cognitive fatigability and CF in PwMS as two distinct concepts.

Sections du résumé

BACKGROUND
Sustained cognitive testing is used to detect cognitive fatigability and is often considered a substitute for subjective cognitive fatigue (CF). However, the relationship between cognitive fatigability and subjective CF in people with multiple sclerosis (PwMS) remains undetermined.
OBJECTIVE
To explore potential associations between fatigability induced by sustained cognitive testing and subjective CF in PwMS.
METHODS
We gave 120 PwMS and 60 demographically matched, healthy individuals the Beck Depression Inventory-FastScreen (BDI-FS) to measure mood and the Modified Fatigue Impact Scale to measure CF. In addition, we used the Quotient ADHD Test, a sustained attention test, to measure cognitive fatigability. We also explored potential correlations between the individuals' performance on the sustained attention test and thalamic volume using recent MRI scans.
RESULTS
Forty-one (34.2%) of the PwMS exhibited cognitive fatigability. These 41 were found to be significantly older (P=0.006), had been diagnosed with the disease for longer (P=0.03), had higher scores (P<0.001) on the Expanded Disability Status Scale, and had reduced thalamic volume (P=0.04) compared with the 79 (65.8%) PwMS not exhibiting cognitive fatigability. The PwMS exhibiting cognitive fatigability scored similarly on the BDI-FS (P=0.21) and self-reported similar rates of CF (P=0.62) as the PwMS not exhibiting cognitive fatigability.
CONCLUSION
Cognitive fatigability induced by sustained cognitive testing is not an accurate clinical alternative to subjective CF. This study provides evidence to support cognitive fatigability and CF in PwMS as two distinct concepts.

Identifiants

pubmed: 32496296
doi: 10.1097/WNN.0000000000000228
pii: 00146965-202006000-00004
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113-121

Auteurs

Christos Bakirtzis (C)

Multiple Sclerosis Center, B' Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Ioannis Nikolaidis (I)

Multiple Sclerosis Center, B' Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Marina-Kleopatra Boziki (MK)

Multiple Sclerosis Center, B' Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Artemios Artemiadis (A)

Medical School, University of Cyprus, Nicosia, Cyprus.

Athina Andravizou (A)

Department of Neurology, University of Thessaly, Larissa, Greece.

Lambros Messinis (L)

Neuropsychology Section, Departments of Psychiatry and Neurology, University Hospital of Patras, Patras, Greece.

Panagiotis Ioannidis (P)

Multiple Sclerosis Center, B' Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Nikolaos Grigoriadis (N)

Multiple Sclerosis Center, B' Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH